Generic Name and Formulations:
Prasterone 6.5mg; per vaginal insert.
Indications for INTRAROSA:
Moderate-to-severe dyspareunia due to menopause.
Use 1 vaginal insert once daily at bedtime.
Undiagnosed abnormal genital bleeding.
Breast cancer or history of. Evaluate undiagnosed, persistent or recurrent genital bleeding prior to initiation. Premenopausal: not indicated. Pregnancy. Nursing mothers.
Vaginal discharge, abnormal Pap smear.
Blister pack—28 (w. applicatiors)
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Men With Migraines May Have Increased Serum Estradiol, Androgen Deficiency
- Fremanezumab Effective in Reversion of Chronic Migraine to Episodic Migraine
- Endocannabinoids May Be Elevated in Women With Fibromyalgia
- Putting Patients in the Physician's Seat: Smartphone Technology Is Changing the Healthcare Landscape
- Cardiovascular, Psychiatric Comorbidity Patterns Evident in Migraine